The U.S. Food and Drug Administration has approved GlaxoSmithKline's combination booster vaccine, Kinrix.
Kinrix protects children between 4 and 6 years old against diphtheria, pertussis, polio and tetanus and is approved for children who previously received GSK's Infanrix, which covers diptheria, tetanus and pertussis and who received Pediarix. Pediarix is a combination vaccine that covers DPT, hepatitis B and polio.
"Children 4 to 6 years-old can receive five or more vaccinations in a single visit, which can be stressful for parents and vaccinators," said William P. Hitchcock, M.D., Assistant Clinical Professor of Pediatrics, University of California, San Diego School of Medicine. "By reducing the number of shots given in one visit, combination vaccines like Kinrix may make it easier for kids to meet school vaccination requirements and CDC recommendations."
Combination vaccines are recommended to reduce the number of vaccine shots a child receives in a single visit.
[Source: CNNMoney]
Comment Preview